📰 Alpha Wave News
Page 7 - Alpha Wave News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpha Wave. Real-time updates on events, politics, business and more.
November 17, 2023
Oura has alleged that Ultrahuman copied its technology and accessed proprietary information. It accused the Indian company of violating patents and copyrights in developing its fitness ring, which was launched in 2022.
November 17, 2023
BharatPes embattled cofounder Ashneer Grover and his wife Madhuri Jain were stopped at the Delhi airport from travelling to New York. This and more in todays ETtech Top 5.
November 7, 2023
UAE-based Alpha Dhabi Holding has reported robust financial results for the first nine months with a 29% increase in net profit surging to AED11.6 billion ($3.2 billion) mainly due to a combination of organic expansion and strategic acquisitions.
November 2, 2023
Alpha Dhabi's diversified portfolio has been a major driver behind the growth in revenue
October 12, 2023
Aye Finance, a non-bank lender, aims to increase its borrowing by 70% to Rs 3,400 crore in FY24 compared to Rs 2,000 crore in FY23. The company has already raised Rs 2,100 crore of debt and is confident of meeting its target. It has secured funds from both global and Indian banks and financial institutions.
October 9, 2023
The company does not need additional capital for its pivot. Most of the $37 million that Virgio raised last year remains in the company’s bank account and gives the company a cash runway of three years, per Nagaram.
October 9, 2023
Virgio, a fashion ecommerce set up by former Myntra CEO Amar Nagaram, will pivot from fast fashion to sustainable fashion.
October 4, 2023
A set of around two dozen investors and their representatives shall go through elevator pitches made by a curated set of startups in the Delhi ......
October 1, 2023
This week, the Indonesian government prohibited social commerce players from making direct transactions on social media platforms.
October 1, 2023
Avalyn Pharma aims to improve treatment of Idiopathic pulmonary fibrosis with inhalable versions of two older oral drugs and it’s now headed for mid-stage testing backed by a Series C financing. Other recent biotech industry financings raised money for research in cancer, immunology, and rare genetic diseases.